The Clorox Company (NYSE:CLX) Shares Purchased by Geode Capital Management LLC

Geode Capital Management LLC increased its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 1.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,028,333 shares of the company's stock after acquiring an additional 33,970 shares during the quarter. Geode Capital Management LLC owned about 2.45% of Clorox worth $491,713,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CLX. Catalyst Capital Advisors LLC purchased a new stake in shares of Clorox in the third quarter valued at approximately $54,000. Raymond James & Associates boosted its stake in Clorox by 32.8% during the second quarter. Raymond James & Associates now owns 267,632 shares of the company's stock worth $36,524,000 after buying an additional 66,149 shares during the last quarter. AQR Capital Management LLC grew its holdings in Clorox by 8.6% in the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company's stock valued at $39,121,000 after buying an additional 22,676 shares in the last quarter. Los Angeles Capital Management LLC increased its stake in shares of Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company's stock worth $31,266,000 after acquiring an additional 10,149 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its holdings in shares of Clorox by 371.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 96,969 shares of the company's stock worth $13,233,000 after acquiring an additional 76,397 shares during the period. Hedge funds and other institutional investors own 78.53% of the company's stock.

Analyst Upgrades and Downgrades

CLX has been the subject of several recent analyst reports. BNP Paribas upgraded shares of Clorox to a "strong sell" rating in a research report on Friday, September 6th. JPMorgan Chase & Co. lifted their price target on shares of Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a research report on Friday, October 11th. TD Cowen upgraded Clorox from a "sell" rating to a "hold" rating and upped their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Barclays raised their target price on Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research note on Friday, November 1st. Finally, Citigroup upped their price target on Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a research note on Friday, September 6th. Five equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $155.00.

Clorox Stock Up 0.2 %

Shares of Clorox stock traded up $0.31 during trading on Friday, hitting $164.96. 753,014 shares of the stock were exchanged, compared to its average volume of 1,229,704. The stock has a market cap of $20.42 billion, a price-to-earnings ratio of 57.38, a price-to-earnings-growth ratio of 3.04 and a beta of 0.42. The firm's 50-day moving average price is $163.70 and its 200 day moving average price is $151.31. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the company earned $0.49 EPS. The business's quarterly revenue was up 27.0% on a year-over-year basis. As a group, analysts forecast that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.96%. The ex-dividend date is Wednesday, January 29th. Clorox's payout ratio is 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.